Skip to content

MCH ANALYSIS RESEARCH Main site ↗

Industrials

Diversified Support Services

7 companies under coverage.

How to read this page

Coverage

Diversified Support Services

Equity Research

Copart Inc (CPRT)

HOLD. 12-month probability-weighted target $30 (+8% vs spot). P/E Multiple explains 82% of Monte Carlo outcome variance.

CPRTEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +17.1%

Equity Research

RB Global Inc. (RBA)

BUY. 12-month probability-weighted target $107 (+25% vs spot). P/E Multiple explains 60% of Monte Carlo outcome variance.

RBAEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +4.1%

Equity Research

KBR Inc (KBR)

HOLD. 12-month probability-weighted target $39 (+11% vs spot). Gross Margin explains 69% of Monte Carlo outcome variance.

KBREquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -12.3%

Equity Research

Leidos Holdings Inc (LDOS)

HOLD. 12-month probability-weighted target $118 (-3% vs spot). Gross Margin explains 63% of Monte Carlo outcome variance.

LDOSEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -14.4%

Equity Research

Cintas Corporation (CTAS)

SELL. 12-month probability-weighted target $170 (-16% vs spot). P/E Multiple explains 66% of Monte Carlo outcome variance.

CTASEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -27.4%

Equity Research

Science Applications International Corporation Common Stock (SAIC)

SELL. 12-month probability-weighted target $117 (-13% vs spot). Gross Margin explains 69% of Monte Carlo outcome variance.

SAICEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -29.4%

Equity Research

CACI International Inc (CACI)

SELL. 12-month probability-weighted target $497 (-19% vs spot). Gross Margin explains 69% of Monte Carlo outcome variance.

CACIEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -36.9%

MCH ANALYSIS · All research · Research, not personal financial advicemchadvisoryservices.com ↗ · Research Standard v4 (decision-level) · Research OS ros-1.20.0 · US-listed

MCH Analysis is a general investment-research publication of MCH Advisory (Pty) Ltd. It is not personal financial advice and does not take your circumstances into account. MCH is not a licensed financial services provider or a registered investment adviser. Past performance, whether actual or simulated, does not predict future results. Subscriber Agreement | Privacy and Cookie Notice | Research Governance Policies